| Rasagiline Rowex 1 mg tablets PA0711/264/001 |
Rasagiline |
Rowex Limited, |
Marketed |
| Rasagiline Teva 1 mg tablets PA1986/017/001 |
Rasagiline |
Teva B.V. |
Not marketed |
| Rasilez 150 mg film-coated tablets EU/1/07/405/021-030 |
Aliskiren hemifumarate |
Lxo Ireland Designated Activity Company |
— |
| Rasilez 300 mg film-coated tablets EU/1/07/405/031-040 |
Aliskiren hemifumarate |
Noden Pharma DAC |
— |
| Ratiograstim 30 MIU/0.5 ml solution for injection EU/1/08/444/1-4 |
Filgrastim |
Ratiopharm GmbH |
— |
| Ratiograstim 48 MIU/0.8 ml solution for injection EU/1/08/444/5-8 |
Filgrastim |
Ratiopharm GmbH |
— |
| RAVICTI 1.1 g/ml oral liquid EU/1/15/1062/001-004 |
Glycerol phenylbutyrate |
Immedica Pharma AB |
— |
| Raxone 150 mg film-coated tablets EU/1/15/1020/001 |
Idebenone |
Chiesi Farmaceutici S.p.A. |
— |
| RAYVOW 100 mg film-coated tablets EU/1/21/1587/011-020 |
Lasmiditan Succinate |
Eli Lilly Nederland B.V. |
— |
| RAYVOW 200 mg film-coated tablets EU/1/21/1587/021-030 |
Lasmiditan Succinate |
Eli Lilly Nederland B.V. |
— |
| RAYVOW 50 mg film-coated tablets EU/1/21/1587/001-010 |
Lasmiditan Succinate |
Eli Lilly Nederland B.V. |
— |
| Razolager 15 mg hard gastro-resistant capsules PA23266/074/001 |
Lansoprazole |
Viatris Limited |
Not marketed |
| Razolager 30 mg hard gastro-resistant capsules PA23266/074/002 |
Lansoprazole |
Viatris Limited |
Not marketed |
| Razole 10 mg Gastro-resistant tablets PA0074/073/001 |
Rabeprazole sodium |
Rowa Pharmaceuticals Limited |
Not marketed |
| Razole 20 mg Gastro-resistant tablets PA0074/073/002 |
Rabeprazole sodium |
Rowa Pharmaceuticals Limited |
Not marketed |
| Reagila 1.5 mg hard capsules EU/1/17/1209/001-010 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 1.5 mg orodispersible tablets EU/1/17/1209/043-044 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 3 mg hard capsules EU/1/17/1209/011-020 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 3 mg orodispersible tablets EU/1/17/1209/045-046 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 4.5 mg hard capsules EU/1/17/1209/021-028 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 4.5 mg orodispersible tablets EU/1/17/1209/047-048 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 6 mg hard capsules EU/1/17/1209/029-036 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 6 mg orodispersible tablets EU/1/17/1209/049-050 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Rebif 22 micrograms solution for injection in pre-filled syringe EU/1/98/063/001,11-13 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 22 micrograms solution for injection in pre-filled syringe EU/1/98/063/002 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 22 micrograms solution for injection in pre-filled syringe EU/1/98/063/003 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 22 micrograms/0.5 mL solution for injection in cartridge EU/1/98/063/008,18 |
Interferon beta-1-a |
Merck Europe B.V. |
— |
| Rebif 44 micrograms solution for injection in pre-filled syringe EU/1/98/063/004 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 44 micrograms solution for injection in pre-filled syringe EU/1/98/063/005 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 44 micrograms solution for injection in pre-filled syringe EU/1/98/063/006 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 44 micrograms/0.5 mL solution for injection in cartridge EU/1/98/063/009,019 |
Interferon beta-1-a |
Merck Europe B.V. |
— |
| Rebif 8.8 micrograms + 22 micrograms solution for injection in pre-filled pen Initiation pack EU/1/98/063/017 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 8.8 micrograms + 22 micrograms solution for injection in pre-filled syringe Starter Pack EU/1/98/063/007 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 8.8 micrograms/0.1 mL + 22 micrograms/0.25 mL solution for injection in cartridge Initiation pack EU/1/98/063/010 |
Interferon beta-1-a |
Merck Europe B.V. |
— |
| Reblozyl 25 mg powder for solution for injection EU/1/20/1452/001 |
Luspatercept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reblozyl 75 mg powder for solution for injection EU/1/20/1452/002 |
Luspatercept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Recarbrio 500 mg/500 mg/250 mg powder for solution for infusion EU/1/19/1420/001 |
Imipenem, Cilastatin, Relebactam |
Merck Sharp & Dohme BV, |
— |
| Rectogesic 4 mg/g Rectal Ointment PA2242/018/001 |
Glyceryl trinitrate |
Grunenthal Pharma Ltd |
Marketed |
| Rectogesic 4 mg/g Rectal Ointment PPA1463/245/001 |
Glyceryl trinitrate |
IMED Healthcare Ltd. |
— |
| Redoxon Double Action 1000 mg/10 mg Effervescent Tablets PA1410/050/001 |
Ascorbic acid, Zinc citrate trihydrate |
Bayer Limited |
Not marketed |
| ReFacto AF 1000 IU powder and solvent for solution for injection EU/1/99/103/003 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 1000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/007 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 2000 IU powder and solvent for solution for injection EU/1/99/103/004 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 2000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/008 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 250 IU powder and solvent for solution for injection EU/1/99/103/001 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 3000 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/005 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 500 IU powder and solvent for solution for injection EU/1/99/103/002 |
Recombinant antihemophilic factor |
Pfizer Europe MA EEIG |
— |
| ReFacto AF 500 IU powder and solvent for solution for injection in pre-filled syringe EU/1/99/103/006 |
Moroctocog alfa |
Pfizer Europe MA EEIG |
— |
| Refixia 1 000 IU powder and solvent for solution for injection EU/1/17/1193/002 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| Refixia 2 000 IU powder and solvent for solution for injection EU/1/17/1193/003 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |